Mind and Skin - the Neurocutaneous Axis in Atopic Eczema

NCT05790330 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-05-03

No results posted yet for this study

Summary

'Mind and Skin': A prospective cohort study evaluating the impact of inflammation, itch and sleep disturbance on the brain, mental health and cognition, in patients with severe atopy.

Conditions

Interventions

DRUG

Methotrexate

As per usual standard of care

DRUG

Dupilumab

As per usual standard of care

Sponsors & Collaborators

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-10
Primary Completion
2025-12-01
Completion
2027-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05790330 on ClinicalTrials.gov